Evolus is a medical aesthetics company dedicated to bringing advanced aesthetic procedures and treatments to physicians and consumers.  Evolus focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex for the treatment of glabellar lines, also known as frown lines, in adult patients.

Visit Evolus www.evolus.com